Latest Breaking News On - Visium cytassist gene - Page 1 : vimarsana.com

10x Genomics, Inc (NASDAQ:TXG) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.

United statesKyle miksonCanaccord genuityDan ariasSerge saxonovCassie corneauJustin mcanearPatrick donnellyDuke universityBeckman coulter life sciences0x genomics incGenomics incExchange commissionUniversity of adelaideXenium panel designerBeckman coulter

10x Genomics : Third Quarter 2023 Prepared Remarks -November 02, 2023 at 06:11 pm EDT

Q3 2023 Earnings Call Prepared Remarks November 2, 2023 Cassie Corneau Head of Investor Relations and Strategic.

United statesJustin mcanearSerge saxonovCassie corneauGenomics incUniversity of adelaideSecurities exchangeExchange commissionBeckman coulterDuke universityBeckman coulter life sciencesXenium panel designerCall prepared remarksInvestor relationsStrategic financeFederal securities

10x Genomics Reports Second Quarter 2023 Financial Results

/PRNewswire/ 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended.

Hong kongUnited statesSerge saxonovGenomics incExchange commissionSecurities exchangeVisium cytassist geneProtein expressionChromiumx seriesConference callPrivate securities litigation reform actSecurities actSecurities exchange actFinancial conditionConsolidated statementsMiddle east

10x Genomics (TXG) Launches Visium CytAssist Gene and Protein Expression Assay

10x Genomics (TXG) Launches Visium CytAssist Gene and Protein Expression Assay
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Visium cytassistMichael schnall levinProfessor of neurology at northwestern universityGenomics incHuman immune cell profiling panelTechnology officerVisium cytassist geneProtein expressionFounding scientistChief technologyCytassist geneAssistant professor

10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay

/PRNewswire/ 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new Visium.

Visium cytassistMichael schnall levinTechnology officerHuman immune cell profiling panelExchange commissionProfessor of neurology at northwestern universityGenomics incSecurities exchangeVisium cytassist geneProtein expressionFounding scientistChief technologyCytassist geneDavid gateAssistant professorPrivate securities litigation reform act